IGC Pharma | 0.3991 -0.0188 -4.50% | ||
| IGC | |||
| 高 0.4250 | 开 0.4170 | 量 67.29万股 | 总市值 3670.09万 |
| 低 0.3925 | 换 0.73% | 额 27.31万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
IGC Pharma(IGC)
08-04 18:15
$IGC Pharma(IGC)$ PRE 14A Other preliminary proxy statements Accession Number: 0001185185-25-000890 Act: 34 Size: 1 MB 网页链接
IGC Pharma(IGC)
07-19 05:25
$IGC Pharma(IGC)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001185185-25-000808 Act: 33 Size: 197 KB 网页链接
IGC Pharma(IGC)
09-20 04:05
$IGC Pharma(IGC)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001185185-25-001235 Act: 33 Size: 306 KB 网页链接
IGC Pharma(IGC)
10-02 04:45
$IGC Pharma(IGC)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001185185-25-001326 Act: 34 Size: 250 KB 网页链接
IGC Pharma(IGC)
08-19 03:05
$IGC Pharma(IGC)$ DEF 14A Other definitive proxy statements Accession Number: 0001185185-25-001021 Act: 34 Size: 1 MB 网页链接
IGC Pharma(IGC)
07-29 18:15
$IGC Pharma(IGC)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002377 Act: 33 Size: 1 KB 网页链接
IGC Pharma(IGC)
08-15 04:15
$IGC Pharma(IGC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001185185-25-000997 Act: 34 Size: 9 MB 网页链接
IGC Pharma(IGC)
08-19 18:05
$IGC Pharma(IGC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001185185-25-001023 Act: 34 Size: 131 KB 网页链接